Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEOPARD: Early ART in HIV-infected Infants
NCT02431975Phase 4Completed
- Sponsor
- Columbia University
- Start
- Aug 2015
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nevirapine, zidovudine, lamivudine, lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Columbia University. Started Aug 2015; status: completed.
02
Drugs
nevirapinezidovudinelamivudinelopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02431975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431975.